Physician profile
Neil A Tayyab
NPI 1831149970
$283,478.23
in general payments reported to CMS, 2019-2025
16 companies · $58K in 2025
The $58K reported for 2025 was more than what 88% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $20K · 2021: $71K · 2022: $60K · 2023: $14K · 2024: $39K · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $96K · Consulting Fee: $11K · Food and Beverage: $3,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $95,733.92 |
| Consulting Fee | $10,862.50 |
| Food and Beverage | $3,923.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seaspine Orthopedics Corporation | $133,405.27 | 2019-2022 | |
| Orthofix Medical, INC. | $118,957.85 | 2019-2025 | Physio-Stim, Waveform C, Miscellaneous |
| Nuvasive, INC. | $25,776.78 | 2019-2023 | Xlif |
| Globus Medical, INC. | $4,679.20 | 2023-2025 | Cohere, Aerial, Alif |
| Spinal Elements, INC. | $240.92 | 2019 | |
| Depuy Synthes Sales INC. | $121.71 | 2019-2024 | Motoband |
| Si-Bone, INC. | $52.78 | 2019-2021 | |
| Viseon, INC. | $43.10 | 2021 | |
| Abbott Laboratories | $37.25 | 2021 | |
| Intrinsic Therapeutics | $32.95 | 2025 | Barricaid Acd (Annular Closure Device) |
| Kerecis Limited | $32.66 | 2022 | |
| Painteq LLC | $25.28 | 2024 | Painteq |
| Heraeus Medical, LLC. | $23.22 | 2021 | |
| Medtronic, INC. | $23.13 | 2022 | |
| Amgen INC. | $14.62 | 2024 | Evenity, Prolia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Tayyab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.